en
Scientific article
English

A generic workflow for the characterization of therapeutic monoclonal antibodies—application to daratumumab

Published inAnalytical and Bioanalytical Chemistry, vol. 411, no. 19, p. 4615-4627
Publication date2019
Abstract

In the present analytical workflow, chromatographic methods have been developed and hyphenated to mass spectrometry (MS) for the characterization of protein size, charge, hydrophobic, and hydrophilic variants of daratumumab. Multiple critical quality attributes (CQAs) were characterized in forced degraded daratumumab sample, using size exclusion, ion exchange (IEX), and hydrophobic interaction (HIC) chromatography coupled to fluorescence detection for relative quantification and fractionation. Mass assignment was performed by using a fast, non-denaturing and universal size exclusion chromatography (SEC) method prior to native MS analysis of the collected fractions (off-line approach). This allowed the identification of N-terminal lysine clipping, and the extent of glycation and oxidation at intact protein level. Finally, middle-up analysis of daratumumab was performed using reversed phase (RPLC) and hydrophilic interaction (HILIC) chromatography coupled to MS to obtain a comprehensive overview of all PTMs after the forced stressed conditions and a fine characterization of the glycosylation profile. Conveniently, the presented workflow maintains the established golden standard non-denaturing chromatography techniques and additionally introduces a straightforward and automated desalting procedure prior to MS analysis. Therefore, it is expected that the off-line coupling of SEC, IEX, and HIC to SEC-MS has great potential to be implemented in routine characterization of mAbs.

Keywords
  • Monoclonal antibodies
  • Size exclusion chromatography
  • Ion exchange chromatography
  • Reversed phase chromatography
  • Hydrophilic interaction chromatography
  • Mass spectrometry
Citation (ISO format)
DUIVELSHOF, Bastiaan et al. A generic workflow for the characterization of therapeutic monoclonal antibodies—application to daratumumab. In: Analytical and Bioanalytical Chemistry, 2019, vol. 411, n° 19, p. 4615–4627. doi: 10.1007/s00216-018-1561-1
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1618-2642
416views
3downloads

Technical informations

Creation07/17/2019 4:49:00 PM
First validation07/17/2019 4:49:00 PM
Update time03/15/2023 5:47:49 PM
Status update03/15/2023 5:47:48 PM
Last indexation01/17/2024 5:54:28 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack